Moderna, Inc.

Moderna, Inc.

Moderna, Inc.

Overview
Date Founded

2010

Headquarters

320 BENT STREET, CAMBRIDGE, MA, 02141

Type of Company

Public

Employees (Worldwide)

830

Industries

Biotechnology
Medical Support Services
Hospitals & Patient Services

Company Description

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Website

http://www.modernatx.com

Contact Data
Trying to get in touch with decision makers at Moderna, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
The New York Times
February 26, 2021
Amid Slow Vaccine Deliveries, Desperate E.U. Nations Hunt for More
South Florida Sun-Sentinel
January 24, 2021
Lucky few hit the vaccine jackpot Some go on waiting lists, while clinics offer up extra doses
Philadelphia Inquirer
January 24, 2021
How doable is Biden's 100 million goal?; To some, vaccinating that many by April is ambitious. To others, he needs to aim higher.
Nasdaq
January 24, 2021
What Are Moderna's Risks?
The Miami Herald
January 23, 2021
France advises delaying second COVID-19 shots to speed vaccines

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Noubar Afeyan

Co-Founder

Stéphane Bancel

Director & Chief Executive Officer

Stephen Hoge

President

David Meline

Chief Financial Officer

Lori M. Henderson

General Counsel & Corporate Secretary

Corinne Le Goff

Chief Commercial Officer

Melanie Ivarsson

Chief Development Officer

Melissa Moore

Ph.D.Chief Scientific Officer

Marcello Damiani

Chief Digital & Operational Excellence Officer

Tal Zaks

Chief Medical Officer

Board of Directors
Noubar Afeyan

Co-Founder at Moderna, Inc.

Stéphane Bancel

Director & Chief Executive Officer at Moderna, Inc.

Paul Sagan

Investment Team at General Catalyst LLC

Sandra J. Horning

Emeritus Professor of Medicine at Stanford University - School of Medicine

Elizabeth E. Tallett

Member-Sports Board at The University of Nottingham

Stephen Berenson

Managing Partner at Flagship Pioneering

Francois Nader

Former President, Chief Executive Officer & Director, NPS Pharmaceuticals, Inc at NPS Pharmaceuticals, Inc.

Trending People
Page Street Publishing Co.
Author Steve Wollett's new book "God's Assassin" is a spellbinding thriller foll... - PR Newswire
The Pratt & Whitney Co., Inc.
Damage to fan blade in United Boeing 777 engine consistent with metal fatigue -N... - Nasdaq
HSBC Holdings Plc
HSBC's annual profit falls 34% as COVID-19 takes toll - Nasdaq
Trending Organizations
Page Street Publishing Co.
Author Steve Wollett's new book "God's Assassin" is a spellbinding thriller foll... - PR Newswire
The Pratt & Whitney Co., Inc.
Damage to fan blade in United Boeing 777 engine consistent with metal fatigue -N... - Nasdaq
HSBC Holdings Plc
HSBC's annual profit falls 34% as COVID-19 takes toll - Nasdaq
Paths to Moderna, Inc.
Potential Connections via
Relationship Science
You
Moderna, Inc.
Owners & Shareholders
Details Hidden
Flagship Pioneering

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

Details Hidden
Baillie Gifford & Co.

Baillie Gifford is an active, team-oriented, research-based manager which is completely focused on delivering long-term returns. The firm’s investment philosophy focuses on growth while their universe is global. They employ bottom-up conviction to portfolio construction. Their diversified strategies maximize investment opportunities, aiming to achieve steady returns. For equities, Baillie Gifford’s analysts conduct qualitative, fundamental analysis to identify the most competitive, innovative and efficient growth companies. For multi-asset strategy, the firm invests in various asset classes such as listed equities, property, high yield credit, commodities, emerging market government bonds and insurance linked securities. For fixed-income, Baillie Gifford invests in government bonds and currencies, emerging market bonds, investment grade and high yield.

Details Hidden
Thélème Partners LLP

Thélème is an active manager which manages a global long/short equity strategy fund, investing primarily in US equities and also in European, Asian and emerging market equities. The firm does not plan to take activist positions.

Recent Transactions
Details Hidden

Moderna, Inc. issued USD Common Stock

Details Hidden

Moderna, Inc. issued USD Common Stock

Details Hidden

Moderna, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Stéphane Bancel

Details Hidden
Stephen Hoge

Details Hidden
Tal Zaks

Transaction Advisors
Escrow Agent
Computershare Trust Co., NA

Advised onModerna, Inc. issued USD Common Stock

Legal Advisor
Goodwin Procter LLP

Advised onModerna, Inc. issued USD Common Stock

Underwriter
Morgan Stanley & Co. LLC

Advised onModerna, Inc. issued USD Common Stock

Legal Advisor
Gregg Katz

Advised onModerna, Inc. issued USD Common Stock

Associate
Patricia Mets

Advised onModerna, Inc. issued USD Common Stock

Global Chair, Mergers & Acquisitions
Stuart M. Cable

Advised onModerna, Inc. issued USD Common Stock
Advisors & Consultants
Consultant
Peter Barton Hutt

Professor at Harvard University
Clients
Merck & Co., Inc.

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Bill & Melinda Gates Foundation Trust

The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington.

AstraZeneca Plc

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Key Stats and Financials As of 2019
Market Capitalization
$63.1B
Total Enterprise Value
$5.5B
Earnings Per Share
$-1.55
Net Profit
$-514M
EBITDA
$-515M
EBITDAMargin
-854.85%
Total Debt
$136M
Total Equity
$1.17B
Enterprise Value / Sales
91.39x
TEVNet Income
-10.7x
Revenue
$60.2M
Debt TEV
0.02x
Three Year Compounded Annual Growth Rate Of Revenue
-17.8%
Non-Profit Donations & Grants
$10K - $15K
2018
International Institute of New England, Inc.

Investors
Details Hidden
Flagship Pioneering

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

Details Hidden
Doug Cole

Managing Partner at Flagship Pioneering

Details Hidden
Noubar Afeyan

Co-Founder at Moderna, Inc.

Suppliers
mRNA RiboTherapeutics, Inc. Biotechnology | Madison, WISCONSIN

mRNA RiboTherapeutics, Inc. provides products and technology for making and using ribonucleic acid for translation in cells for clinical research and therapeutics. It offers products for MRNA production in vitro transcription, post-transcriptional capping, co--transcriptional capping, post-transcriptional tailing, modified NTP in vitro transcription, mRNA decapping, and RNase inhibition. The company is headquartered in Madison, WI.

Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust. It engages in the ownership, operation, development, and redevelopment of life science and technology properties. The firm also provides a space for lease to the life science and technology industries, which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Lonza Group AG Pharmaceuticals | Basel, Che

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.

Competitors
GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Amicus Therapeutics, Inc. Pharmaceuticals - Cranbury, New Jersey

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with rare metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Cranbury, NJ.

Takeda Pharmaceutical Co., Ltd. Pharmaceuticals - Osaka, Japan

Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Takeda's ethical drugs are marketed in around 100 countries worldwide.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Moderna, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Moderna, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Moderna, Inc..